131796-63-9,MFCD00868632
Catalog No.:AA009HSG

131796-63-9 | (S)-8-Chloro-5-(2,3-dihydrobenzofuran-7-yl)-3-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-ol

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
99%
in stock  
$333.00   $233.00
- +
25mg
99%
in stock  
$1,020.00   $714.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA009HSG
Chemical Name:
(S)-8-Chloro-5-(2,3-dihydrobenzofuran-7-yl)-3-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-ol
CAS Number:
131796-63-9
Molecular Formula:
C19H20ClNO2
Molecular Weight:
329.8206
MDL Number:
MFCD00868632
SMILES:
CN1CCc2c([C@H](C1)c1cccc3c1OCC3)cc(c(c2)Cl)O
Properties
Computed Properties
 
Complexity:
420  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
4  

Literature

Title: Altered dopamine D2 receptor binding in atypical facial pain.

Journal: Pain 20031101

Title: Effects of dopamine antagonists on alfentanil-induced locomotor activity in horses.

Journal: Veterinary anaesthesia and analgesia 20030701

Title: Striatal dopamine D1 and D2 receptors in burning mouth syndrome.

Journal: Pain 20030101

Title: New and old antipsychotics versus clozapine in a monkey model: adverse effects and antiamphetamine effects.

Journal: Psychopharmacology 19990601

Title: Abi-Dargham A, et al. PET studies of binding competition between endogenous dopamine and the D1 radiotracer 1CNNC 756. Synapse. 1999 May;32(2):93-109.

Title: Nielsen EB, et al. Dopamine receptor occupancy in vivo: behavioral correlates using NNC-112, NNC-687 and NNC-756, new selective dopamine D1 receptor antagonists. Eur J Pharmacol. 1992 Aug 14;219(1):35-44.

Title: J. VANGGAARD ANDERSEN, et al. Normal-phase liquid chromatography-particle-beam mass spectrometry in drug metabolism studies of the dopamine receptor antagonist Odapipam and the muscarine M1 receptor agonist Xanomeline. Xenobiotica. 1997, 27: 901-912.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 131796-63-9
Tags:131796-63-9 Molecular Formula|131796-63-9 MDL|131796-63-9 SMILES|131796-63-9 (S)-8-Chloro-5-(2,3-dihydrobenzofuran-7-yl)-3-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-ol
Catalog No.: AA009HSG
131796-63-9,MFCD00868632
131796-63-9 | (S)-8-Chloro-5-(2,3-dihydrobenzofuran-7-yl)-3-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-ol
Pack Size: 5mg
Purity: 99%
in stock
$333.00 $233.00
Pack Size: 25mg
Purity: 99%
in stock
$1,020.00 $714.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA009HSG
Chemical Name: (S)-8-Chloro-5-(2,3-dihydrobenzofuran-7-yl)-3-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-ol
CAS Number: 131796-63-9
Molecular Formula: C19H20ClNO2
Molecular Weight: 329.8206
MDL Number: MFCD00868632
SMILES: CN1CCc2c([C@H](C1)c1cccc3c1OCC3)cc(c(c2)Cl)O
Properties
Complexity: 420  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 1  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 23  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 1  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 4  
Literature fold

Title: Altered dopamine D2 receptor binding in atypical facial pain.

Journal: Pain20031101

Title: Effects of dopamine antagonists on alfentanil-induced locomotor activity in horses.

Journal: Veterinary anaesthesia and analgesia20030701

Title: Striatal dopamine D1 and D2 receptors in burning mouth syndrome.

Journal: Pain20030101

Title: New and old antipsychotics versus clozapine in a monkey model: adverse effects and antiamphetamine effects.

Journal: Psychopharmacology19990601

Title: Abi-Dargham A, et al. PET studies of binding competition between endogenous dopamine and the D1 radiotracer 1CNNC 756. Synapse. 1999 May;32(2):93-109.

Title: Nielsen EB, et al. Dopamine receptor occupancy in vivo: behavioral correlates using NNC-112, NNC-687 and NNC-756, new selective dopamine D1 receptor antagonists. Eur J Pharmacol. 1992 Aug 14;219(1):35-44.

Title: J. VANGGAARD ANDERSEN, et al. Normal-phase liquid chromatography-particle-beam mass spectrometry in drug metabolism studies of the dopamine receptor antagonist Odapipam and the muscarine M1 receptor agonist Xanomeline. Xenobiotica. 1997, 27: 901-912.

Building Blocks More >
122775-34-2
122775-34-2
3-Iodochromone
AA009IFP | MFCD09475514
141524-73-4
141524-73-4
(4-bromo-1-methyl-1H-imidazol-5-yl)methanol
AA009IYH | MFCD02179537
1400220-51-0
1400220-51-0
3-Bromo-2-fluorophenylboronic acid pinacol ester
AA009JOZ | MFCD22192539
1190044-30-4
1190044-30-4
4-(AMinoMethyl)tetrahydro-1-thiapyran-4-ol-1,1-dioxide HCl
AA009K3V | MFCD16660449
1087659-32-2
1087659-32-2
(5-Bromo-3-methoxypyridin-2-yl)methanol
AA009LZ6 | MFCD11857646
1094108-02-7
1094108-02-7
3-(2-ETHOXYETHOXY)PYRROLIDINE HYDROCHLORIDE
AA009NRG | MFCD09879227
1142201-78-2
1142201-78-2
6-Hydrazino-3-methylpyrimidine-2,4(1h,3h)-dione
AA009Q7O | MFCD00457033
103987-83-3
103987-83-3
1-Nitro-2-naphthoic acid
AA009SJ8 | MFCD06203335
1251017-31-8
1251017-31-8
Trans-1,3,3a,4,5,9b-hexahydro-pyrrolo[3,4-c]quinoline-2-carboxylic acid tert-butyl ester
AA009VGT | MFCD14581151
1226812-52-7
1226812-52-7
N-Hydroxy-2,3:5,6-bis-o-(1-methylethylidene)-alpha-d-glucofuranosylamine
AA009VZP | MFCD15530194
Submit
© 2017 AA BLOCKS, INC. All rights reserved.